These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1579232)

  • 1. Differential glucocorticoid effects on the fusion of Duchenne/Becker and control muscle cultures: pharmacologic detection of accelerated aging in dystrophic muscle.
    Hardiman O; Brown RH; Beggs AH; Specht L; Sklar RM
    Neurology; 1992 May; 42(5):1085-91. PubMed ID: 1579232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylprednisolone selectively affects dystrophin expression in human muscle cultures.
    Hardiman O; Sklar RM; Brown RH
    Neurology; 1993 Feb; 43(2):342-5. PubMed ID: 8437700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired muscle differentiation in explant cultures of Duchenne muscular dystrophy.
    Jasmin G; Tautu C; Vanasse M; Brochu P; Simoneau R
    Lab Invest; 1984 Feb; 50(2):197-207. PubMed ID: 6694359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro.
    Sklar RM; Brown RH
    J Neurol Sci; 1991 Jan; 101(1):73-81. PubMed ID: 2027030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy.
    Oexle K; Zwirner A; Freudenberg K; Kohlschütter A; Speer A
    Pediatr Res; 1997 Aug; 42(2):226-31. PubMed ID: 9262227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
    Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R
    J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures.
    Corbett AJ
    Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis and muscle differentiation in a girl with severe muscular dystrophy.
    Meola G; Scarpini E; Velicogna M; Scarlato G; Larizza L; Conti AF
    J Neurol; 1986 Jun; 233(3):168-70. PubMed ID: 3723154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a maturation defect related to calcium in muscle mitochondria from dystrophic mice and Duchenne and Becker muscular dystrophy patients.
    Lucas-Héron B; Mussini JM; Ollivier B
    J Neurol Sci; 1989 May; 90(3):299-306. PubMed ID: 2738610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased creatine kinase activity in cultured Duchenne dystrophic muscle cells.
    Iannaccone ST; Nagy B; Samaha FJ
    J Child Neurol; 1987 Jan; 2(1):17-21. PubMed ID: 3624824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective dystrophin in Duchenne and Becker dystrophy myotubes in cell culture.
    Sklar RM; Beggs AH; Lev AA; Specht L; Shapiro F; Brown RH
    Neurology; 1990 Dec; 40(12):1854-8. PubMed ID: 1701042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture.
    Mawatari S; Miranda A; Rowland LP
    Neurology; 1976 Nov; 26(11):1021-6. PubMed ID: 988507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between Duchenne and other muscular dystrophies by ribosomal protein synthesis.
    Ionasescu V
    J Med Genet; 1975 Mar; 12(1):49-54. PubMed ID: 164552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
    Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible manifestation of the dystrophic X chromosome in muscle cultures from carriers of Duchenne muscular dystrophy.
    Thompson EJ; Yasin R; Lake BD; Cavanagh NP
    Exp Neurol; 1983 Mar; 79(3):720-8. PubMed ID: 6825761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of methylprednisolone on intracellular calcium of normal and dystrophic human skeletal muscle cells.
    Vandebrouck C; Imbert N; Duport G; Cognard C; Raymond G
    Neurosci Lett; 1999 Jul; 269(2):110-4. PubMed ID: 10430517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effects of drugs for protein synthesis on muscle cell cultures in Duchenne dystrophy.
    Ionasescu V; Stern LZ; Ionasescu R; Rubenstein P
    Ann Neurol; 1979 Feb; 5(2):107-10. PubMed ID: 426472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerated muscle fibers in Duchenne muscular dystrophy: a serial section study.
    Schmalbruch H
    Neurology; 1984 Jan; 34(1):60-5. PubMed ID: 6537854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.